as 12-18-2024 11:39am EST
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Founded: | 2021 | Country: | United States |
Employees: | N/A | City: | DALLAS |
Market Cap: | 6.3M | IPO Year: | 2023 |
Target Price: | N/A | AVG Volume (30 days): | 59.1K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -5.65 | EPS Growth: | N/A |
52 Week Low/High: | $2.10 - $16.80 | Next Earning Date: | 11-14-2024 |
Revenue: | $755,000 | Revenue Growth: | 52.20% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
MGRX Breaking Stock News: Dive into MGRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
14 days ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
Newsfile
2 months ago
TipRanks
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
The information presented on this page, "MGRX Mangoceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.